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Abstract
Background
Non-cardiac chest pain is common and there is no formal recommendation on what diag-
nostic tests to use to identify underlying diseases after an acute coronary syndrome has
been ruled out.
Objective
To evaluate the diagnostic tests, treatment recommendations and initiated treatments in
patients presenting with non-cardiac chest pain to the emergency department (ED).
Methods
Single-center, retrospective medical chart review of patients presenting to the ED.
Included were all medical records of patients aged 18 years and older presenting to the
ED with chest pain and a non-cardiac discharge diagnosis between January 1, 2009 and
December 31, 2011. Information on the diagnosis, diagnostic tests performed, treatment
initiated and recommendation for further diagnostic testing or treatment were extracted.
The primary outcomes of interest were the final diagnosis, diagnostic tests, and treatment
recommendations. A formal ACS rule out testing was defined as serial three troponin
testing.
Results
In total, 1341 ED admissions for non-cardiac chest pain (4.2% of all ED admissions) were
analyzed. Non-specific chest pain remained the discharge diagnosis in 44.7% (n = 599).
Identified underlying diseases included musculoskeletal chest pain (n = 602, 44.9%), pulmo-
nary (n = 30, 2.2%), GI-tract (n = 35, 2.6%), or psychiatric diseases (n = 75, 5.6%). In 81.4%
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at least one troponin test and in 89% one ECG were performed. A formal ACS rule out tropo-
nin testing was performed in 9.2% (GI-tract disease 14.3%, non-specific chest pain 14.0%,
pulmonary disease 10.0%, musculoskeletal chest pain 4.7%, and psychiatric disease
4.0%). Most frequently analgesics were prescribed (51%). A diagnostic test with proton
pump inhibitor (PPI) was prescribed in 20% (mainly in gastrointestinal diseases). At dis-
charge, over 72 different recommendations were given, ranging from no further measures
to extensive cardiac evaluation.
Conclusion
In this retrospective study, a formal work-up to rule out ACS was found in a minority of
patients presenting to the ED with chest pain of non-cardiac origin. A wide variation in diag-
nostic processes and treatment recommendations reflect the uncertainty of clinicians on
how to approach patients after a cardiac cause was considered unlikely. Panic and anxiety
disorders were rarely considered and a useful PPI treatment trial to diagnose gastroesopha-
geal reflux disease was infrequently recommended.
Introduction
The top priority in patients presenting with chest pain to the emergency department (ED) is to
rule out a potentially life-threatening disease such as an acute coronary syndrome (ACS), pul-
monary embolism, aortic dissection, or pneumonia. After a thorough diagnostic work-up, an
acute myocardial ischemia can be ruled out for 60% to 90% of patients presenting with chest
pain [1–4]. While in specialized units, including cardiac care units and intensive care units, the
proportion of patients with ACS may be higher [5], the percentage of patients in the ED with
ACS decreased in the US from 23.6% in 1999–2000 to 13.0% in 2007–2008 [6]. When no spe-
cific disease causing the chest pain can be identified, patients are usually discharged with the
diagnosis of non-cardiac chest pain (NCCP).
Patients with NCCP can be categorized in patients with and without an identifiable under-
lying disease (i.e. non-specific chest pain). It has been suggested that up to 50% of the patients
discharged with NCCP have an underlying gastrointestinal reflux [7] or a psychiatric disease
[8, 9]. Further, chest pain is frequently the result of musculoskeletal diseases [10]. Whereas the
mortality rates among patients discharged with NCCP from the ED is low [11], 90% com-
plained of persisting symptoms and impaired quality of life at a 4-year follow-up [12]. Despite
normal coronary angiograms, 44% of patients with NCCP still believed they suffer from an
underlying cardiac disease and 50% reported limitations in performing their daily activities
[13]. Therefore, a primary focus on ruling out cardiovascular disease in patients with NCCP
may result in overtesting without improving the patients’ confidence. Further, elevated tropo-
nin test results can be found in patients without chest pain or ischemic electrocardiographic
changes and, in a retrospective study, elevated troponin test results had no clinical utility but
resulted in downstream testing [14].
Therefore, the clinical challenge is to determine which diagnostic tests to apply in patients
with chest pain after a cardiac disease has been ruled out in order to discriminate between
patients with non-specific chest pain and other underlying diseases presenting with NCCP.
For example, a high dose proton pump inhibitor (PPI) treatment trial may be useful to identify
patients with underlying gastroesophageal reflux disease (GERD) and screening tools may
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identify patients with an underlying panic or anxiety disorder [15]. To date, the diagnostic pro-
cesses and the treatment recommendations in patients discharged from the ED with a diagno-
sis of NCCP are poorly investigated and mainly based on the physicians’ personal beliefs and
experiences.
The objective of this retrospective study was to gather knowledge about the diagnostic steps
in the ED and the treatment recommendations for patients discharged from the ED with a
diagnosis of NCCP. We analyzed the frequency of discharge diagnoses, the performed diag-
nostic tests, the initiated treatments, and the treatment recommendations. We hypothesized
that the majority of patients were discharged with a musculoskeletal or non-specific disease
and the diagnostic assessment focused mainly on ruling out of an ACS. Further, we hypothe-
sized that a high-dose PPI treatment trial to identify patients with GERD related chest pain
was infrequently used and psychiatric diseases rarely considered.
Methods
Single-center, retrospective medical chart review of patients presenting to one of the ten largest
hospitals in Switzerland, the Cantonal Hospital Winterthur, between January 1, 2009 and
December 31, 2011. The study period was chosen because an outpatient clinic opened in 2012
and therefore, many patients eligible for this study were potentially treated elsewhere. The hos-
pital is affiliated to the University of Zurich and covers the medical services for approximately
200’000 persons (15 percent of the inhabitants of the canton Zu¨rich).
Patient selection
Potentially eligible medical records were identified by using prespecified diagnostic German
International Classification of Disease Version 10 (ICD-10-GM) codes coded by ED physi-
cians: R06.4 (hyperventilation), R07.1 (chest pain when breathing), R07.2 (precordial pain),
R07.3 (other chest pain), and R07.4 (chest pain not further specified).
Eligibility criteria
Included were all medical records of patients age 18 years and older presenting to the ED with
chest pain and a non-cardiac discharge diagnosis between January 1, 2009 and December 31,
2011. Excluded were patients with chest pain of cardiovascular origin, pregnant women,
trauma patients or life-threatening conditions, malignant disease, current fracture, renal
replacement therapy or severe kidney failure (creatinine clearance of less than 30ml/min/
1.73m2) as well as patients with incapacitation or records of patients which opted out of releas-
ing their records for scientific purposes.
Data extraction procedure
All records identified by this search were screened by two researchers (TD, SM) for inclusion
or exclusion. In case of uncertainty, the records were discussed with the principal investigator
(MW) and disagreement was resolved within the research group. Each patient included in the
study was assigned a unique de-identified number. We defined the first presentation for chest
pain to the ED as the index consultation for the first episode. During the following three
months each presentation (to the ED, outpatient consultation, hospitalization) was considered
potentially related to the index consultation and was defined as a follow-up consultation. Pre-
sentations to the ED or hospitalizations after more than three months due to chest pain were
defined as a new index visit of a second episode.
Evaluation of non-cardiac chest pain patients in the emergency department
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Variables of interest were predefined and the extraction form was pilot-tested in 20 records.
To ensure high quality in the data extraction, TD and SM were trained and monitored by MW
and an extraction manual was used. We extracted information on general characteristics (age,
gender), cardiovascular risk factors, signs and symptoms at presentation, preexisting comor-
bidities, medications, clinical findings at presentation, blood analyses, ECG, imaging studies,
coronary angiography, non-invasive testing (e.g. treadmill testing, cardiac scintigraphy, echo-
cardiography) and other tests/investigations. Further information on discharge medications,
discharge diagnosis, recommended procedures / investigations after discharge were extracted.
Study endpoint
The main study endpoints of interests were the final diagnosis, performed diagnostic tests, and
treatment recommendations. The final diagnosis was based on the discharge diagnosis
extracted from the discharge letters. In patients with re-visits to an outpatient clinic or the ED
any additional follow-up assessment and reports were reviewed and screened for changes in
the discharge diagnosis. In patients with differences between the discharge diagnosis and the
diagnosis on follow-up visits, the final diagnosis was adjudicated by a research committee (JS,
UH, JB, MW)–blinded to the details of index visit–based on the results of the follow-up evalua-
tion and records of re-hospitalizations. Each final diagnosis was assigned to one of the five cat-
egories: musculoskeletal chest pain, gastrointestinal chest pain, pulmonary chest pain, chest
pain in psychiatric diseases, and non-specific chest pain.
We defined a formal ACS rule out testing as serial troponin tests performed at presentation,
a second (after 3 to 6 hours), and a third (beyond 6 hours) [16]. Additional endpoints were:
recommendations on further evaluation after discharge, and re-visits to the ED.
Data quality and statistical analysis
The quality of the data extraction was assessed by a researcher not involved in the extraction
process (BK). In total, six predefined parameters (troponin test result, pain reproducible by
movement, coronary angiography, recommendation for further diagnostic evaluation, recom-
mendation for further treatment, and the discharge diagnosis) in 379 ED visits were reviewed.
The quality of data extraction was high with an error rate of 5.4% (95% CI 4.5–6.4).
We calculated median and interquartile ranges for continuous variables, numbers and per-
centages of total for binary or categorical variables. A chi-squared test was used for group com-
parisons for categorical variables and Kruskal-Wallis test was used for continuous variables
between groups. Differences between the diagnostic categories were visualized using bar plots.
All analyses were performed with the statistical software R [17].
Ethical review board approval
Due to the retrospective nature of the study, data extraction did not interfere or influence the
treatment of patients. The study was approved by the independent Ethics Committee of the
Canton Zurich, Switzerland (KEK-ZH number 2014–0506, approved in December 2014) and
complied with international standards including the declaration of Helsinki, good clinical
practice, and the Swiss law for research in human subjects.
Results
Out of 31,902 visits to the ED, 2,438 records with the ICD-10 codes R07.1–4 were screened
and 1,341 ED admissions for non-cardiac chest pain (4.2%, Table 1) were finally analyzed.
The main discharge diagnoses were musculoskeletal chest pain (n = 602, 45%) and non-
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Table 1. Baseline characteristics.
Overall MSD Non-specific Pulmonary GI Tract Psychiatric p-value
Number of patients 1341 602 599 30 35 75
% of the population 100.0 44.9 44.7 2.2 2.6 5.6
Age 46.0 [33.0, 60.0] 40.5 [30.0, 55.0] 49.0 [38.0, 64.0] 60.0 [33.0, 68.0] 56.0 [41.5, 63.0] 43.0 [29.5, 53.0] <0.001
Male 604 (45.0) 265 (44.0) 269 (44.9) 12 (40.0) 13 (37.1) 45 (60.0) 0.08
Profession <0.001
Employee/white collar 295 (22.0) 162 (26.9) 107 (17.9) 5 (16.7) 2 (5.7) 19 (25.3)
Blue collar 137 (10.2) 74 (12.3) 51 (8.5) 1 (3.3) 4 (11.4) 7 (9.3)
Disabled 21 (1.6) 13 (2.2) 5 (0.8) 1 (3.3) 1 (2.9) 1 (1.3)
Non-working 133 (9.9) 71 (11.8) 41 (6.8) 4 (13.3) 4 (11.4) 13 (17.3)
Retired 179 (13.3) 64 (10.6) 94 (15.7) 7 (23.3) 5 (14.3) 9 (12.0)
Unknown 576 (43.0) 218 (36.2) 301 (50.3) 12 (40.0) 19 (54.3) 26 (34.7)
Marital status <0.001
Divorced 146 (10.9) 69 (11.5) 67 (11.2) 4 (13.3) 3 (8.6) 3 (4.0)
No relationship 289 (21.6) 157 (26.1) 99 (16.5) 8 (26.7) 3 (8.6) 22 (29.3)
Relationship 8 (0.6) 2 (0.3) 4 (0.7) 0 (0.0) 1 (2.9) 1 (1.3)
Married 781 (58.2) 334 (55.5) 368 (61.4) 13 (43.3) 22 (62.9) 44 (58.7)
Widowed 81 (6.0) 25 (4.2) 41 (6.8) 5 (16.7) 6 (17.1) 4 (5.3)
Unknown 36 (2.7) 15 (2.5) 20 (3.3) 0 (0.0) 0 (0.0) 1 (1.3)
Presentation at ER <0.001
By ambulance 200 (14.9) 70 (11.6) 99 (16.5) 3 (10.0) 6 (17.1) 22 (29.3)
No 690 (51.5) 370 (61.5) 247 (41.2) 18 (60.0) 17 (48.6) 38 (50.7)
Unknown 451 (33.6) 162 (26.9) 253 (42.2) 9 (30.0) 12 (34.3) 15 (20.0)
Referral <0.001
Self-referral 1105 (82.4) 524 (87.0) 466 (77.8) 23 (76.7) 26 (74.3) 66 (88.0)
Physician referral 232 (17.3) 78 (13.0) 130 (21.7) 6 (20.0) 9 (25.7) 9 (12.0)
Not reported 4 (0.3) 0 (0.0) 3 (0.5) 1 (3.3) 0 (0.0) 0 (0.0)
CVD risk factors
BMI 25.8 [23.2, 29.1] 25.6 [23.0, 28.8] 26.1 [23.9, 29.4] 24.8 [23.3, 26.6] 28.4 [24.8, 32.2] 25.4 [22.0, 28.5] 0.03
Smoking: current 254 (18.9) 109 (18.1) 116 (19.4) 3 (10.0) 9 (25.7) 17 (22.7) <0.001
Stopped 153 (11.4) 45 (7.5) 94 (15.7) 5 (16.7) 5 (14.3) 4 (5.3)
Never 255 (19.0) 96 (15.9) 128 (21.4) 5 (16.7) 13 (37.1) 13 (17.3)
Not reported 679 (50.6) 352 (58.5) 261 (43.6) 17 (56.7) 8 (22.9) 41 (54.7)
Family history of CVD 210 (15.7) 80 (13.3) 109 (18.2) 3 (10.0) 9 (25.7) 9 (12.0) <0.001
No 332 (24.8) 118 (19.6) 174 (29.0) 10 (33.3) 15 (42.9) 15 (20.0)
Not reported 799 (59.6) 404 (67.1) 316 (52.8) 17 (56.7) 11 (31.4) 51 (68.0)
Known CVD 459 (34.2) 151 (25.1) 258 (43.1) 11 (36.7) 16 (45.7) 23 (30.7) <0.001
No 630 (47.0) 317 (52.7) 251 (41.9) 15 (50.0) 15 (42.9) 32 (42.7)
Not reported 252 (18.8) 134 (22.3) 90 (15.0) 4 (13.3) 4 (11.4) 20 (26.7)
Previous acute MI 116 (8.7) 31 (5.1) 73 (12.2) 1 (3.3) 7 (20.0) 4 (5.3) <0.001
No 1023 (76.3) 482 (80.1) 438 (73.1) 25 (83.3) 23 (65.7) 55 (73.3)
Not reported 89 (14.8) 88 (14.7) 4 (13.3) 5 (14.3) 16 (21.3) 89 (14.8)
PAD 11 (0.8) 3 (0.5) 7 (1.2) 0 (0.0) 0 (0.0) 1 (1.3) 0.66
No 1101 (82.1) 505 (83.9) 484 (80.8) 26 (86.7) 29 (82.9) 57 (76.0)
Not reported 229 (17.1) 94 (15.6) 108 (18.0) 4 (13.3) 6 (17.1) 17 (22.7)
History of stroke 26 (1.9) 6 (1.0) 13 (2.2) 3 (10.0) 2 (5.7) 2 (2.7) 0.015
No 1109 (82.7) 505 (83.9) 494 (82.5) 24 (80.0) 29 (82.9) 57 (76.0)
Not reported 206 (15.4) 91 (15.1) 92 (15.4) 3 (10.0) 4 (11.4) 16 (21.3)
Diabetes mellitus 69 (5.1) 22 (3.7) 38 (6.3) 1 (3.3) 1 (2.9) 7 (9.3) 0.032
No 1107 (82.2) 520 (86.4) 472 (78.8) 26 (86.7) 30 (85.7) 56 (74.7)
(Continued)
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specific chest pain (n = 599, 45%). Musculoskeletal diagnosis were mainly non-specific related
to the chest wall (90%) or to the spine (3%). Specific musculoskeletal diagnosis were found in a
few patients (fractured rip n = 5, late onset rheumatoid arthritis n = 1, and contusion n = 3). In
a small proportion of patients the diagnostic work-up resulted in a pulmonary (n = 30, 2%),
GI-tract (n = 35, 2%), or psychiatric diseases (n = 75, 6%).
Baseline presentation
The majority of patients were female (55%), married (58%), and the median age was 46 years
(IQR 33–60, Table 1). Cardiovascular disease was known in 34.2% (previous acute myocardial
infarction in 8.7%), a history of peripheral arterial disease in 0.8%, stroke in 1.9%, and diabetes
mellitus in 5.1%. Overall, 32% of the patients met the definition for multimorbidity (� two
known diseases). Further details are summarized in Table 1 and S1 Table.
ED evaluation
Diagnostic evaluation was mainly performed on an outpatient basis (90.2%, Table 2). The
diagnostic work-up with regards to vital signs was comparable in all categories: blood pressure
Table 1. (Continued)
Overall MSD Non-specific Pulmonary GI Tract Psychiatric p-value
Not reported 168 (12.5) 60 (10.0) 89 (14.9) 3 (10.0) 4 (11.4) 12 (16.0)
Medication use
Diabetes mellitus therapy 0.37
Diet 4 (0.3) 1 (0.2) 3 (0.5) 0 (0.0) 0 (0.0) 0 (0.0)
Oral antidiabetic drugs 47 (3.5) 17 (2.8) 25 (4.2) 1 (3.3) 0 (0.0) 4 (5.3)
Insulin 18 (1.3) 4 (0.7) 10 (1.7) 0 (0.0) 1 (2.9) 3 (4.0)
Acetylsalicylic acid use 218 (16.3) 64 (10.6) 128 (21.4) 5 (16.7) 9 (25.7) 12 (16.0) <0.001
No 995 (74.2) 477 (79.2) 416 (69.4) 23 (76.7) 24 (68.6) 55 (73.3)
Not reported 128 (9.5) 61 (10.1) 55 (9.2) 2 (6.7) 2 (5.7) 8 (10.7)
Statin use 178 (13.3) 51 (8.5) 107 (17.9) 3 (10.0) 11 (31.4) 6 (8.0) <0.001
No 1031 (76.9) 490 (81.4) 434 (72.5) 25 (83.3) 22 (62.9) 60 (80.0)
Not reported 132 (9.8) 61 (10.1) 55 (9.2) 2 (6.7) 2 (5.7) 8 (10.7)
Antihypertensive therapy 357 (26.6) 112 (18.6) 205 (34.2) 10 (33.3) 11 (31.4) 19 (25.3) <0.001
No 854 (63.7) 429 (71.3) 337 (56.3) 18 (60.0) 22 (62.9) 48 (64.0)
Not reported 130 (9.7) 61 (10.1) 57 (9.5) 2 (6.7) 2 (5.7) 8 (10.7)
PPI 162 (12.1) 49 (8.1) 89 (14.9) 3 (10.0) 12 (34.3) 9 (12.0) <0.001
No 1047 (78.1) 491 (81.6) 452 (75.5) 25 (83.3) 21 (60.0) 58 (77.3)
Not reported 132 (9.8) 62 (10.3) 58 (9.7) 2 (6.7) 2 (5.7) 8 (10.7)
Analgesics 194 (14.5) 94 (15.6) 80 (13.4) 6 (20.0) 5 (14.3) 9 (12.0) 0.91
No 1020 (76.1) 449 (74.6) 463 (77.3) 22 (73.3) 28 (80.0) 58 (77.3)
Not reported 127 (9.5) 59 (9.8) 56 (9.3) 2 (6.7) 2 (5.7) 8 (10.7)
Antipsychotics 175 (13.0) 59 (9.8) 93 (15.5) 4 (13.3) 5 (14.3) 14 (18.7) 0.17
No 1035 (77.2) 481 (79.9) 450 (75.1) 24 (80.0) 27 (77.1) 53 (70.7)
Not reported 131 (9.8) 62 (10.3) 56 (9.3) 2 (6.7) 3 (8.6) 8 (10.7)
Values in median [IQR], n (%); p-values refer to all columns except for the overall. A chi-squared test was used for all variables except Age and BMI where Kruskal-
Wallis was used.
MSD, musculoskeletal diseases; GI, gastrointestinal; CVD, cardiovascular disease; PAD, peripheral arterial disease; BMI, body mass index; PPI, proton pump inhibitor;
Gyn, gynecological; not reported, no information available in the electronical records.
https://doi.org/10.1371/journal.pone.0211615.t001
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measurements in 91.6%, oxygen saturation or the respiratory rate in 74.8%, and body tempera-
ture in 51.1%. Overall, in 89% of the patients an ECG, in 91.9% at least one blood analysis, and
in 81.4% at least one troponin test was performed. Fig 1 shows the proportion of patients for
each diagnostic group with initial and follow-up troponin testing. The proportion of initial tro-
ponin testing varied between 90% (non-specific chest pain 90.3% and GI-diseases 90.4%) and
below 75% (musculoskeletal chest pain 72.9%, pulmonary diseases 60%, and psychiatric dis-
eases 73.3%). A second follow-up troponin test was performed in 42.7% and a formal ACS rule
out with a third troponin test in 9.2% (Table 2 and S2 Table). The formal ACS rule out testing
was performed in patients with GI-tract diseases (14.3%), non-specific chest pain (14.0%), pul-
monary diseases (10.0%), musculoskeletal chest pain (4.7%), and psychiatric diseases (4.0%).
Table 2. Diagnostic evaluations in patients with non-cardiac chest pain.
Overall MSD Non-specific Pulmonary GI-tract Psychiatric p
Patients: n 1341 602 599 30 35 75
Outpatient evaluation 1209 (90.2) 577 (95.8) 517 (86.3) 19 (63.3) 28 (80) 68 (90.7) <0.001
Inpatient evaluation 132 (9.8) 25 (4.2) 82 (13.7) 11 (36.7) 7 (20.0) 7 (9.3)
Intensive care unit 6 (0.4) 1 (0.2) 3 (0.5) 2 (6.7) 0 (0.0) 0 (0.0) <0.001
Vital signs
Arterial BP recorded 1229 (91.6) 556 (92.4) 544 (90.8) 26 (86.7) 32 (91.4) 71 (94.7) 0.59
BP measurement both sides 904 (67.4) 395 (65.6) 416 (69.4) 23 (76.7) 21 (60.0) 49 (65.3) 0.38
SO2 or respiratory rate 1003 (74.8) 464 (77.1) 431 (72.0) 24 (80.0) 24 (68.6) 60 (80.0) 0.17
Temperature 685 (51.1) 311 (51.7) 302 (50.4) 17 (56.7) 16 (45.7) 39 (52.0) 0.91
Lab and ECG testing
Laboratory (any) 1233 (91.9) 527 (87.5) 581 (97.0) 26 (86.7) 34 (97.1) 65 (86.7) <0.001
ECG 1194 (89.0) 506 (84.1) 568 (94.8) 24 (80.0) 32 (91.4) 64 (85.3) <0.001
Troponin test at presentation 1091 (81.4) 439 (72.9) 547 (91.3) 18 (60.0) 32 (91.4) 55 (73.3) <0.001
Not measured 250 (18.6) 163 (27.1) 52 (8.7) 12 (40.0) 3 (8.6) 20 (26.7)
Troponin 2˚ Test‡ 572 (42.7) 173 (28.7) 355 (59.3) 6 (20.0) 23 (65.7) 15 (20.0) <0.001
Troponin 3˚ Test‡ 123 (9.2) 28 (4.7) 84 (14.0) 3 (10.0) 5 (14.3) 3 (4.0) 0.001
Additional tests: n (%)
Tread mill test 35 (2.6) 8 (1.3) 26 (4.3) 0 (0.0) 1 (2.9) 0 (0.0) 0.008
Echocardiography 65 (4.8) 18 (3.0) 38 (6.3) 1 (3.3) 2 (5.7) 6 (8.0) 0.06
MIBI scintigraphy 9 (0.7) 0 (0.0) 9 (1.5) 0 (0.0) 0 (0.0) 0 (0.0) 0.02
Coronary angiography 40 (3.0) 8 (1.3) 30 (5.0) 0 (0.0) 1 (2.9) 1 (1.3) 0.003
Chest x-ray 789 (58.8) 339 (56.3) 383 (63.9) 22 (73.3) 21 (60.0) 24 (32.0) <0.001
Chest CT scan 114 (8.5) 46 (7.6) 51 (8.5) 8 (26.7) 5 (14.3) 4 (5.3) 0.003
Abdominal CT scan 13 (1.0) 4 (0.7) 8 (1.3) 0 (0.0) 1 (2.9) 0 (0.0) 0.44
Abdominal sonography 45 (3.4) 10 (1.7) 26 (4.3) 5 (16.7) 4 (11.4) 0 (0.0) <0.001
Gastroscopy 13 (1.0) 1 (0.2) 7 (1.2) 0 (0.0) 4 (11.4) 1 (1.3) <0.001
Pulmonary function test 11 (0.8) 4 (0.7) 6 (1.0) 0 (0.0) 0 (0.0) 1 (1.3) 0.88
Pleura sonography 5 (0.4) 2 (0.3) 1 (0.2) 2 (6.7) 0 (0.0) 0 (0.0) <0.001
Patients requiring surgery 3 (0.2) 1 (0.2) 2 (0.3) 0 (0.0) 0 (0.0) 0 (0.0) 0.95
Other interventions 82 (6.1) 25 (4.2) 36 (6.0) 3 (10.0) 1 (2.9) 17 (22.7) <0.001
‡ details on the time between baseline and follow-up testing are provided in S2 Table.
SO2, oxygen saturation
MSD, musculoskeletal diseases; GI, gastrointestinal; CVD, cardiovascular disease; PAD, peripheral arterial disease; CT, computer tomography; MIBI,
methoxyisobutylisonitrile
Chi-squared tests were used for all variables.
https://doi.org/10.1371/journal.pone.0211615.t002
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The most frequently performed additional diagnostic test was a chest x-ray (58.9%).
Around 10% of all patients were hospitalized (0.4% in an intensive care unit). Additional eval-
uation using a tread mill test was performed in 2.6%, echocardiography in 4.8%, MIBI scintig-
raphy in 0.7%, and coronary angiography in 3.0%. Fig 2 shows the differences in the use of
these test for each diagnostic groups. In non-specific chest pain, tread mill tests, MIBI scintig-
raphy, and coronary angiography were most often performed. Echocardiography was most
often performed in patients with a psychiatric discharge diagnosis.
Recommendations at discharge and initiated treatments
Overall, 76 different recommendations at discharge were identified. In Table 3 the most fre-
quent recommendations and initiated treatments are summarized. In 17% of the patients fur-
ther cardiac evaluation (treadmill testing 9.1%, least often coronary angiography 0.2%) was
recommended followed by a GP follow-up or a GP initiated assessment/action (16.6%). In
patients with non-specific chest pain cardiac evaluation and GP follow-up was most often rec-
ommended (26.5% and 20.8%, respectively). Whereas a psychiatric evaluation was
Fig 1. Initial ECG and troponin testing in patients non-cardiac chest pain groups. MSD, musculoskeletal chest pain; non-specific, non-
specific chest pain; pulmonary, pulmonary diseases; GI-tract, gastrointestinal tract related chest pain; Psychiatric, chest pain related to
psychiatric conditions.
https://doi.org/10.1371/journal.pone.0211615.g001
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recommended in very few patients (<1%), anxiolytics or psychological treatment was most
often initiated in patients with psychiatric discharge diagnosis (18.7%).
Newly initiated acetylsalicylic acid (ASS) treatment was found in 3.5% and for statins in
2.3% of patients. Analgesics were used by 51% of all patients (musculoskeletal chest pain cate-
gory 66%). The most frequently newly prescribed analgesic was paracetamol (30.4%), followed
by NSAIDs (23.2%), and metamizole (17.2%). PPI use was found in 20.5% of patients. Fig 3
shows the differences in the use of medications. The highest proportion of PPI use was found
in patients with GI-tract disease (71.4%) and non-specific chest pain diagnoses (25.7%). Anti-
psychotics were used in 15.4% of the patients with the majority in patients with psychiatric
diagnoses (25.3%).
Recurrent visits were recorded in 13.1% mainly with emergency readmissions (8.1%) and
outpatient visits (3.3%). Whereas 50% were related to the first emergency visit, 50% were due
to other reasons. The highest proportion of related visits was found in patients with pulmonary
chest pain (23.3%) and a GI-tract disease (20%). Technical evaluations in the outpatient setting
at the same hospital were found in less than 5% of the patients.
Fig 2. Additional non-invasive and invasive tests for cardiac diseases. MSD, musculoskeletal chest pain; non-specific, non-specific chest
pain; pulmonary, pulmonary diseases; GI-tract, gastrointestinal tract related chest pain; Psychiatric, chest pain related to psychiatric
conditions.
https://doi.org/10.1371/journal.pone.0211615.g002
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Table 3. Summary of recommendations, initiated treatment and follow-up evaluations.
overall MSD Non-specific Pulmonary GI-tract Psychiatric p
Number: n 1341 602 599 30 35 75
Recommendations at discharge (main): n (%)
Further imaging studies 21 (1.6) 8 (1.3) 9 (1.5) 3 (10) 1 (2.9) 0 (0) <0.001
Further cardiac assessment 228 (17) 55 (9.1) 159 (26.5) 1 (3.3) 4 (11.4) 9 (12) <0.001
Further gastroenterological assessment 42 (3.1) 5 (0.8) 27 (4.5) 0 (0) 6 (17) 4 (5.3) <0.001
Psychiatric evaluation 12 (0.9 5 (0.8) 4 (0.7) 3 (10) 0 (0) 0 (0) <0.001
Pneumological evaluation 19 (1.4) 7 (1.2) 8 (1.3) 1 (3.3) 0 (0) 3 (4)
Other evaluations 25 (1.9) 10 (1.7) 7 (1.2) 1 (3.3) 4 (11.4) 3 (4) <0.001
PPI treatment 30 (2.2) 6 (1.0) 16 (2.7) 0 (0) 7 (0.2) 1 (1.3)
Anxiolytics / psychological treatment 45 (3.4) 11 (1.8) 19 (3.2) 1 (3.3) 0 (0) 14 (18.7)
GP assessment or action 72 (5.4) 32 (6.3) 29 (4.8) 2 (6.7) 4 (11.4) 5 (6.7)
GP follow-up 150 (11.2) 41 (6.8) 96 (16.0) 2 (6.7) 4 (11.4) 7 (9.3)
Musculoskeletal evaluation or PT treatment 20 (1.5) 14 (2.3) 5 (0.8) 0 (0) 0 (0) 1 (1.3)
Analgesic treatment 35 (2.6) 26 (6.4) 8 (1.3) 0 (0) 1 (2.9) 0 (0.0) 0.013
Medications: n (%)
ASS 100mg use: any 265 (19.8) 71 (11.8) 168 (28.0) 5 (16.7) 9 (25.7) 12 (16.0) <0.001
ASS at presentation only 9 (0.7) 3 (0.5) 4 (0.7) 1 (3.3) 0 (0.0) 1 (1.3) 0.38
ASS at discharge only 47 (3.5) 7 (1.2) 40 (6.7) 0 (0.0) 0 (0.0) 0 (0.0) <0.001
ASS at presentation and discharge 209 (15.6) 61 (10.1) 124 (20.7) 4 (13.3) 9 (25.7) 11 (14.7) <0.001
Statin use: any 209 (15.6) 62 (10.3) 123 (20.5) 4 (13.3) 11 (31.4) 9 (12.0) <0.001
Statin at presentation only 7 (0.5) 6 (1.0) 1 (0.2) 0 (0.0) 0 (0.0) 0 (0.0) 0.31
Statin at discharge only 31 (2.3) 11 (1.8) 16 (2.7) 1 (3.3) 0 (0.0) 3 (4.0) 0.58
Statin at presentation and discharge 171 (12.8) 45 (7.5) 106 (17.7) 3 (10.0) 11 (31.4) 6 (8.0) <0.001
Analgesic use: any 689 (51) 397 (66) 245 (41) 19 (63) 12 (34) 16 (21) <0.001
Analgesics at presentation only 12 (0.9) 3 (0.5) 6 (1.0) 0 (0.0) 2 (5.7) 1 (1.3) 0.03
Analgesics at discharge only 496 (37.0) 303 (50.3) 166 (27.7) 13 (43.3) 7 (20.0) 7 (9.3) <0.001
Analgesics at presentation + discharge 181 (13.5) 91 (15.1) 73 (12.2) 6 (20.0) 3 (8.6) 8 (10.7) 0.34
Novel analgesic at discharge for:
NSAID 312 (23.2) 209 (34.7) 89 (14.9) 11 (36.7) 1 (2.9) 2 (2.7) <0.001
Paracetamol 407 (30.4) 244 (40.5) 142 (23.7) 9 (30.0) 4 (11.4) 8 (10.7) <0.001
Opioid 13 (0.9) 8 (1.3) 5 (0.8) 0 (0) 0 (0) 0 (0) 0.85
Metamizole 230 (17.2) 149 (24.8) 67 (11.2) 7 (23.3) 4 (11.4) 3 (4.0) <0.001
PPI use: any 276 (20.5) 78 (13) 154 (25.7) 5 16.7) 25 (71.4) 14 (18.7) <0.001
PPI at presentation only 11 (0.8) 4 (0.7) 5 (0.8) 0 (0.0) 2 (5.7) 0 (0.0) 0.02
PPI at discharge only 114 (8.5) 29 (4.8) 65 (10.9) 2 (6.7) 13 (37.1) 5 (6.7) <0.001
PPI at presentation + discharge 151 (11.3) 45 (7.5) 84 (14.0) 3 (10.0) 10 (28.6) 9 (12.0) <0.001
Antipsychotic use: any 206 (15.4) 68 (11.3) 108 (18) 6 (20) 5 (14.3) 19 (25.3) 0.002
Antipsychotics at presentation only 17 (1.3) 7 (1.2) 7 (1.2) 1 (3.3) 0 (0.0) 2 (2.7) 0.6
Antipsychotics at discharge only 33 (2.5) 9 (1.5) 17 (2.8) 2 (6.7) 0 (0.0) 5 (6.7) 0.02
Antipsychotics presentation + discharge 156 (11.6) 52 (8.6) 84 (14.0) 3 (10.0) 5 (14.3) 12 (16.0) 0.04
Recurrent visit: any, n (%) 176 (13.1) 58 (9.6) 85 (14.2) 11 (36.7) 10 (28.6) 12 (16.0) <0.001
Outpatient visit 44 (3.3) 11 (1.8) 29 (4.8) 1 (3.3) 2 (5.7) 1 (1.3) <0.001
Elective hospitalization 21 (1.6) 3 (0.5) 10 (1.7) 4 (13.3) 3 (8.6) 1 (1.3)
Emergency readmission 108 (8.1) 43 (7.1) 46 (7.7) 4 (13.3) 5 (14.3) 10 (13.3)
Emergency readmission with hospitalization 3 (0.2) 1 (0.2) 0 (0.0) 2 (6.7) 0 (0.0) 0 (0.0)
Recurrent visit: related to first ED admission 88 (6.6) 18 (3.0) 48 (8.0) 7 (23.3) 7 (20.0) 8 (10.7) <0.001
not related / other reasons 88 (6.6) 40 (6.6) 37 (6.2) 4 (13.3) 3 (8.6) 4 (5.3)
(Continued)
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Discussion
The major finding of this study is that chest pain of non-cardiac origin accounted for 4.2% of all
ED visits and the diagnostic evaluation included in a minority of patients a formal cardiologic
work-up with sequential cardiac troponin testing. In the majority of patients musculoskeletal
chest pain or a non-specific chest pain was the discharge diagnosis and psychiatric diseases were
rarely considered. Over 72 different recommendations at discharge were given, ranging from no
further measures to extensive cardiac evaluation. Despite the recommendation for cardiologic fol-
low-up evaluation in one fifth of the patients, ASS treatment was initiated in only a small propor-
tion of those patients. The most frequently initiated treatment was analgesics where mainly
paracetamol was prescribed. A diagnostic test with proton pump inhibitor was prescribed in 20%
of patients without specific recommendations about the follow-up assessment.
Results compared to the literature
NCCP account for a relevant number of emergency department visits. The prevalence of
NCCP reported in this study was comparable to a previous study where patients with NCCP
accounted for 5% of all ED visits [18]. In the general population, the point prevalence of
NCCP may be up to 25% [19]. For example, in a population-based survey in the Olmested
County, Minnesota (United States), NCCP was reported by 23% of participants [20]. In
patients presenting to the ED with chest pain, 78% consulted a healthcare provider–most com-
monly general practitioners and cardiologists–in the 12 months previous to the ED presenta-
tion [21]. It has been suggested that approximately in two thirds an underlying disease can be
identified [22–24].
Proton pump inhibitor treatment trials are highly effective to identify patients with under-
lying gastroesophageal reflux diseases [15]. Further, panic disorders were common in patients
presenting with chest pain to the ED and were rarely recognized by physicians but resulted in
more testing and referrals [25]. Therefore, the clinical challenge is to determine which
Table 3. (Continued)
overall MSD Non-specific Pulmonary GI-tract Psychiatric p
Outpatient evaluation: n (%)
Chest x-ray 40 (3.0) 8 (1.3) 19 (3.2) 9 (30.0) 2 (5.7) 2 (2.7) <0.001
Chest CT 13 (1.0) 2 (0.3) 4 (0.7) 7 (23.3) 0 (0.0) 0 (0.0) <0.001
Abdominal CT 4 (0.3) 0 (0.0) 1 (0.2) 2 (6.7) 1 (2.9) 0 (0.0) <0.001
Abdominal sonography 15 (1.1) 3 (0.5) 7 (1.2) 2 (6.7) 3 (8.6) 0 (0.0) <0.001
Gastroscopy 10 (0.7) 2 (0.3) 4 (0.7) 0 (0.0) 4 (11.4) 0 (0.0) <0.001
Coloscopy 2 (0.1) 1 (0.2) 1 (0.2) 0 (0.0) 0 (0.0) 0 (0.0) <0.001
Treadmill Test 10 (0.7) 0 (0.0) 9 (1.5) 0 (0.0) 1 (2.9) 0 (0.0) <0.001
Echocardiography 15 (1.1) 3 (0.5) 11 (1.8) 1 (3.3) 0 (0.0) 0 (0.0) <0.001
MIBI scintigraphy 15 (1.1) 3 (0.5) 12 (2.0) 0 (0.0) 0 (0.0) 0 (0.0) <0.001
Coronary angiography 8 (0.6) 0 (0.0) 7 (1.2) 0 (0.0) 1 (2.9) 0 (0.0) <0.001
Pulmonary function test 4 (0.3) 1 (0.2) 2 (0.3) 1 (3.3) 0 (0.0) 0 (0.0) <0.001
Pleura sonography 4 (0.3) 2 (0.3) 0 (0.0) 2 (6.7) 0 (0.0) 0 (0.0) <0.001
Surgery 4 (0.3) 1 (0.2) 0 (0.0) 1 (3.3) 2 (5.7) 0 (0.0) <0.001
Other interventions 36 (2.7) 5 (0.8) 25 (4.2) 3 (10.0) 1 (2.9) 2 (2.7) <0.001
Values in n (%); p-values refer to all columns except for the overall. Chi-squared tests were used for all variables.MSD, musculoskeletal diseases; GI, gastrointestinal;
CVD, cardiovascular disease; PAD, peripheral arterial disease; BMI, body mass index; PPI, proton pump inhibitor; Gyn, gynecological; CT, computer tomography;
NSAID, non-steroidal anti-inflammatory drugs; .GP, general practitioner; PT, physical therapist; ASS, acetylic salicylic acid.
https://doi.org/10.1371/journal.pone.0211615.t003
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diagnostic tests to apply in patients with chest pain after a cardiac disease has been ruled out to
discriminate between patients with non-specific chest pain and other underlying diseases pre-
senting with NCCP. In particular because patients with NCCP experience recurrent pain and a
decreased quality of life [26].
This study showed that a primary focus to rule out an acute coronary syndrome (ACS) by
extending ECG and cardiac troponin testing to all patients with chest pain in an ED may result
in more diagnostic tests without improving the diagnostic and treatment algorithm in the
majority of patients. It is important to consider that patients can have elevated troponin levels
without cardiac diseases and elevated troponin test may result in more downstream testing
without clinical utility [14]. In our study population, no baseline ECG and troponin test was
performed in up to 30% and formal ACS rule out testing for fewer than 20%. The diagnoses in
those cases was based on the physicians’ clinical assessment of the patients’ history, clinical
findings and risk profile. Comparable to our study, in a prospective study of 108 patients with
atypical chest pain presenting to an ED in England, treadmill tests (in 9.3% vs. 2.6% in our
study), echocardiography (6.5% vs. 4.8%), coronary angiography (4.6% vs. 3%), and
Fig 3. Medications at discharge in non-cardiac chest pain groups. MSD, musculoskeletal chest pain; non-specific, non-specific chest pain;
pulmonary, pulmonary diseases; GI-tract, gastrointestinal tract related chest pain; Psychiatric, chest pain related to psychiatric conditions;
ASS, acetylsalicylic acid; PPI, proton pump inhibitor.
https://doi.org/10.1371/journal.pone.0211615.g003
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gastroscopy (5.6% vs. 1%) were performed in a minority of patients (despite an older mean age
of 60 vs. 46 years) [27].
To the best of our knowledge, this was the first study that assessed diagnostic processes and
treatment recommendations in patients with NCCP. We found a lack of clinical concepts to
assess and treat patients with chest pain after an ACS has been ruled out. Other strategies
shown to be effective or useful were not recommended by physicians. For example, a positive
response to a high dose PPI treatment trial for one or two weeks indicates an underlying
GERD whereas a negative response rules out GERD and can help primary care physicians to
further evaluate their patients [15, 28]. According to a Cochrane review cognitive-behavioral
therapy may have a short-term effect in patients with chest pain and normal angiogram [29].
However, psychological assessment was recommended in only 3.4% of all patients in this
study. Despite the frequency of musculoskeletal chest pain, there is only limited evidence on
how to diagnose and treat these patients [30–34]. Physicians use a combination of indicators
including the patients’ history and systematic palpation of the spine and chest wall [31]. The
treatment strategy found in this study included the prescription of analgesics. Musculoskeletal
evaluation and treatment by physical therapists was recommended in 1.5% of the patients. It is
unclear what the natural course of patients with musculoskeletal chest pain is and whether
more intensive management in some patients may be necessary. In a randomized clinical
study that compared manual therapy to self-management, more than one third of the patients
complained about chest pain in both groups at the one year follow-up [35].
Strengths and limitations
While this study was conducted using rigorous predefined protocols and the data extraction
quality was high, there are limitations to consider.
The main limitation is the retrospective nature of this study. Patients were identified by
ICD-10 codes for non-specific chest pain and therefore, patients with other diseases presenting
with chest pain may have been missed. However, the prevalence of patients with NCCP
reported in this study was comparable to a previous study [18]. While great care was used
when extracting information from the medical charts, we cannot exclude that information was
missed during the process despite a data extraction quality (average error rate of below 6%).
Our findings have limited generalizability because it is based on data of one teaching hospital
and may not apply to other clinical settings. Further, the quality of the discharge diagnosis
depends on the clinical experience of a physician and may be revised later on. More experi-
enced physicians may need less diagnostic tests to define a working diagnosis and initiate a
treatment. However, residents and an attending physician saw most patients in the hospitals.
Therefore, we believe that the study provides an accurate picture of a condition, which in ED
department is managed differently compared to primary care practices. The clinical experience
of physicians and the skills to communicate with patients may be particularly relevant in
patients with non-specific diagnoses including non-cardiac chest pain [13].
Implications for research
This study has several implications for future research. Future studies should assess the impact
of a structured evaluation and treatment recommendation in patients with chest pain after an
ACS has been ruled out. To prevent overdiagnosis and overtreatment, studies that assess the
efficacy of clinical prediction rules to rule out ACS should be compared to clinical judgment
by emergency department physicians. It has been shown that the clinical judgment by ED phy-
sicians was at least equally accurate to rule in or out an ACS compared to the HEART score, a
prediction rule developed in ED patients with chest pain [36].
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Implications for clinical practice
In patients with non-cardiac chest pain, panic disorders and GERD are rarely considered in
the treatment recommendations. This study underscores the need for guidance in patients
with non-specific chest pain. Patients with chest pain of unknown or unspecific origin may
express avoidance and anxiety symptoms [37]. A structured approach with a defined commu-
nication strategy may result in assurance and reduce stress.
Conclusion
In this retrospective study a formal work-up to rule out ACS was found in a minority of
patients presenting to the ED with chest pain of non-cardiac origin. A wide variation in diag-
nostic processes and treatment recommendations reflect the uncertainty of clinicians on how
to approach patients after a cardiac cause is considered unlikely. Panic and anxiety disorders
were rarely considered and a useful PPI treatment trial to diagnose gastroesophageal reflux dis-
ease was infrequently recommended.
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